Press Releases
Samsung Biologics attends CITIC CLSA Investors’ Forum
Samsung Biologics took part in the 30th CITIC CLSA Investors’ Forum in Hong Kong earlier this month.
Organized by CLSA, a leading institutional brokerage and investment group, and its parent company CITIC Securities, the Investors’ Forum is Asia’s largest investor conference, providing a platform for companies to deliver their growth strategies to the global investment community, exchange insights, and build meaningful relationships with investors.
Samsung Biologics was invited to the forum amid strong interest and continuous inquiries from global investors. The Company presented its vision and strategies, and shared its expansion plans during the event.
Over 1,000 senior executives from some 320 companies attended this year’s event for meetings with more than 1,800 investors.
Samsung Biologics took part in the 30th CITIC CLSA Investors’ Forum in Hong Kong earlier this month.
Organized by CLSA, a leading institutional brokerage and investment group, and its parent company CITIC Securities, the Investors’ Forum is Asia’s largest investor conference, providing a platform for companies to deliver their growth strategies to the global investment community, exchange insights, and build meaningful relationships with investors.
Samsung Biologics was invited to the forum amid strong interest and continuous inquiries from global investors. The Company presented its vision and strategies, and shared its expansion plans during the event.
Over 1,000 senior executives from some 320 companies attended this year’s event for meetings with more than 1,800 investors.